about
Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorderHuman skin penetration of selected model mycotoxinsChemical-functional diversity in cell-penetrating peptidesQuality of medicines commonly used in the treatment of soil transmitted helminths and giardia in ethiopia: a nationwide surveyAssessment of Efficacy and Quality of Two Albendazole Brands Commonly Used against Soil-Transmitted Helminth Infections in School Children in Jimma Town, EthiopiaInfluence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice.LC-MS profiling of N-alkylamides in Spilanthes acmella extract and the transmucosal behaviour of its main bio-active spilanthol.Differential microRNA expression analysis in blastocysts by whole mount in situ hybridization and reverse transcription quantitative polymerase chain reaction on laser capture microdissection samples.Brainpeps: the blood-brain barrier peptide database.The potential role of quorum-sensing peptides in oncology.Alkamid database: Chemistry, occurrence and functionality of plant N-alkylamides.The effect of morphine on regional cerebral blood flow measured by 99mTc-ECD SPECT in dogs.Quorumpeps database: chemical space, microbial origin and functionality of quorum sensing peptides.Crosstalk between the microbiome and cancer cells by quorum sensing peptides.The quorum sensing peptides PhrG, CSP and EDF promote angiogenesis and invasion of breast cancer cells in vitro.Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier.Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and ImplementationVariation of inflammatory dynamics and mediators in primiparous cows after intramammary challenge with Escherichia coli.Transdermal behaviour of the N-alkylamide spilanthol (affinin) from Spilanthes acmella (Compositae) extracts.Identification of a microscopically selected microorganism in milk samples.Reactive oxygen species generation by bovine blood neutrophils with different CXCR1 (IL8RA) genotype following Interleukin-8 incubation.Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo.Laser capture microdissection of intestinal tissue from sea bass larvae using an optimized RNA integrity assay and validated reference genes.Mucosal and blood-brain barrier transport kinetics of the plant N-alkylamide spilanthol using in vitro and in vivo models.Characterization data on the topical carrier DDC642.A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products.Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.Growth factor/peptide receptor imaging for the development of targeted therapy in oncology.Quality specifications for peptide drugs: a regulatory-pharmaceutical approach.An integrated view on how the management of the dry period length of lactating cows could affect mammary biology and defence.In vivo imaging of apoptosis in oncology: an update.Chiral nickel(II) complexes in the preparation of 11C- and 18F-labelled enantiomerically pure α-amino acids.Development of peptide and protein based radiopharmaceuticals.Related impurities in peptide medicines.Investigation of active pharmaceutical ingredient loss in pharmaceutical compounding of capsules.Regulatory development of geriatric medicines: To GIP or not to GIP?Fish Hydrolysates: A Regulatory Perspective of Bioactive Peptides.Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocRaman spectroscopy and multivariate analysis for the rapid discrimination between native-like and non-native states in freeze-dried protein formulations.Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine.
P50
Q28258361-ED416463-ECAB-4ADA-85F2-E89BB559566AQ28269999-5B825B86-CDDA-4DFD-9B1A-B3330CD8556EQ28535219-9FED2577-3774-4B41-B4D8-8403498D1F01Q28542519-0411D01B-967E-4725-B05D-5DCAAD2EDAB0Q28548540-5D2C07C9-5558-43B6-9731-21802F46DACCQ31031822-CB9F63A7-5C07-4994-80BF-E430B7EBDDF9Q34103816-18482BB5-8CD3-49C7-A508-CD129137FCD4Q34151035-A2F92645-4087-4BB6-8AF6-4D79CDB0F0A7Q34243408-2AEC6F9A-4152-4C1D-BAA8-282B12DDE918Q34269088-15866ABD-8AA8-4286-B35D-F78E20C3AAC2Q34278613-0494C02C-EF9C-499F-BD44-072022540769Q34309063-2D710066-44CA-4FC7-ACAF-FFB13F263F36Q34313705-EFE70C53-E404-449A-BED1-AB17C4AAC046Q34456575-94DB54B6-54A7-4D4B-8577-CB7CE3DE3A6DQ34467527-69644EF1-EC0F-4581-B984-0BCEA14A6ECFQ34500499-62127498-B535-4D2D-8048-60D6E546552EQ34532348-1ABE1A49-9713-489E-A5BC-5C108B6368E4Q34569593-79507A15-3F39-4598-B21E-7DB0F4F89F32Q35006805-83005799-78A0-4AD8-B1E5-EC06BCA9F973Q35056867-AFAFF5FE-C966-4426-8235-905B29168FA6Q35568953-89A54337-C953-4B03-B176-D1F86F5B37E7Q35806512-8FE2F161-3A4E-4023-934F-21BA196E60A7Q35925356-A5E1BF2F-8099-413A-A31A-EEFFEBAA3F9FQ36050847-92731843-6451-4416-B5B2-25C05176BC73Q36074568-F28DAB48-1CEB-4B60-8C6E-2253055169C8Q36835073-2708F5A7-6499-4724-A184-50D30ED15234Q36876057-55E029F4-4752-4717-8160-5207699548B4Q37347382-142B8FBD-F627-4F9E-B5C0-F05D44DB7C34Q37596298-83C85444-DED2-45D3-9891-82BAD63B7698Q37764923-74429F87-E545-41BB-9D9E-B4CFB768F024Q37869237-F9323485-AD0C-405D-A667-49A23E8123A5Q37967152-8D6D33F1-ED9F-4949-84A5-0A05214389B4Q38136363-BCAE34C7-F72C-4538-9827-5F887F4DA69AQ38231960-0B6C7C8D-430F-4007-A88E-D0A712E8A11FQ38417884-3185E78E-2DE7-45E8-9D00-942BFB36E36AQ38743357-9BDC05EA-931A-4991-84F9-59861F56A03BQ38997543-7A2626C0-99CC-412D-B367-86B2A4CC97E5Q39300732-96CDA60B-860B-4476-BB90-1F0FAA31E9B6Q39420637-FCECB16D-2A80-4A88-90C9-05B6B83BEE3FQ39557345-F1216EF0-E1C7-4638-8221-A595D8E8ABB8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bart De Spiegeleer
@ast
Bart De Spiegeleer
@en
Bart De Spiegeleer
@es
Bart De Spiegeleer
@sl
type
label
Bart De Spiegeleer
@ast
Bart De Spiegeleer
@en
Bart De Spiegeleer
@es
Bart De Spiegeleer
@sl
prefLabel
Bart De Spiegeleer
@ast
Bart De Spiegeleer
@en
Bart De Spiegeleer
@es
Bart De Spiegeleer
@sl
P1053
A-2001-2008
P106
P1153
12140513300
P21
P31
P3829
P496
0000-0001-6794-3108